Craft

Neuprozyme Therapeutics

Neuprozyme Therapeutics Summary

Company Summary

Overview
Neuprozyme Therapeutics is a company developing therapies for respiratory diseases. Its drug candidate, XPZ-35, is an oral once-daily inhibitor of dipeptidyl peptidase I (DPPI) for the treatment of inflammation in Cystic Fibrosis.
Type
Private
Status
Active
Founded
2018
HQ
Hørsholm, DK | view all locations
Cybersecurity rating
Sectors

Table of Contents

LocationsView all

1 location detected

  • Hørsholm HQ

    Denmark

    Agern Alle 3

Footer menu